Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a functional therapy for a
plethora of hematologic malignancies and immune disorders. Graft‐versus‐host disease …

Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) with donor lymphocyte
infusion is the mainstay of treatment for many types of hematological malignancies, but the …

Extracellular vesicles (EVs) derived from human mesenchymal stem cells (hMSCs) have
been widely known to have therapeutic effects by representing characteristics of the origin …

Acute graft-versus-host disease (aGVHD) continues to be a frequent and devastating
complication of allogeneic hematopoietic stem cell transplantation (HSCT), posing as a …

Abstract MicroRNA-155 (miR-155) is a small noncoding RNA critical for the regulation of
inflammation as well as innate and adaptive immune responses. MiR-155 has been shown …

Allogeneic hematopoietic stem cell transplantation is a curative treatment for numerous
hematological malignancies. However, acute graft-versus-host disease (aGvHD) is a major …

Currently, acute graft-versus-host disease (aGVHD) diagnosis is based on clinical features
and pathological findings. Until now, there is no non-invasive diagnostic test for aGVHD …

The outcome of hematopoietic stem cell transplantation (HSCT) is controlled by genetic
factors among which the leukocyte antigen human leukocyte antigen (HLA) matching is most …

MicroRNAs (miRNA) have emerged as central regulators of diverse biological processes
and contribute to driving pathology in several diseases. Acute graft-versus-host disease …

Allogeneic hematopoietic stem cell transplantation (HCT) is a well-established treatment for
many malignant and non-malignant hematological disorders. As frequent complication in up …